Discontinued — last reported Q2 '22
Hershey Short-Term Borrowings decreased by 22.5% to $169.46M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.2%, from $144.63M to $169.46M. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 24.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $207.56M | $410.37M | $939.42M | $873.78M | $914.92M | $793.87M | $693.79M | $603.09M | $859.77M | $819.88M | $719.84M | $1.29B | $1.32B | $1.20B | $1.31B | $144.63M | $164.97M | $214.96M | $218.55M | $169.46M |
| QoQ Change | — | +97.7% | +128.9% | -7.0% | +4.7% | -13.2% | -12.6% | -13.1% | +42.6% | -4.6% | -12.2% | +79.2% | +2.5% | -9.5% | +9.2% | -88.9% | +14.1% | +30.3% | +1.7% | -22.5% |
| YoY Change | — | — | — | — | +340.8% | +93.5% | -26.1% | -31.0% | -6.0% | +3.3% | +3.8% | +113.8% | +53.7% | +45.9% | +81.6% | -88.8% | -87.5% | -82.0% | -83.3% | +17.2% |